PASSAGE BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.48 USD | +0.68% |
|
+4.96% | +46.53% |
| 03-04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-04 | Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PASSAGE BIO, INC. | Bio Therapeutic Drugs | +0.68% | +4.96% | +46.53% | +46.53% | - | 90.57M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- PASG Stock
- Charts Passage Bio, Inc.
- Comparison Chart